BRAFV600E-mutant thyroid cancers have a high MAPK output because this class 1 BRAF-mutant signals as a monomer and is insensitive to the negative feedback effects of ERK on activated RAF dimers (Yao et al. 2015). This evidence concerns the gene BRAF and thyroid cancer.